Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study

SIMPLE SUMMARY: The prognosis of patients with primary disseminated multifocal Ewing sarcoma (PDMES) remains dismal. Previously, a combination of temozolomide and irinotecan (TEMIRI) was tested in patients with refractory or relapsed disease. The aim of our study was to evaluate the activity and tol...

Descripción completa

Detalles Bibliográficos
Autores principales: Asaftei, Sebastian Dorin, Puma, Nadia, Paioli, Anna, Petraz, Marco, Morosi, Carlo, Podda, Marta, Tamburini, Angela, Palmerini, Emanuela, Coccoli, Luca, Grignani, Giovanni, Manzitti, Carla, Bertulli, Rossella, De Leonardis, Francesco, Rabusin, Marco, Campello, Anna, Tirtei, Elisa, Picci, Piero, Prete, Arcangelo, Longhi, Alessandra, Fagioli, Franca, Luksch, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234176/
https://www.ncbi.nlm.nih.gov/pubmed/34207428
http://dx.doi.org/10.3390/cancers13123046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234176/
https://www.ncbi.nlm.nih.gov/pubmed/34207428
http://dx.doi.org/10.3390/cancers13123046

Ejemplares similares